Comments

Iterum Therapeutics

ITRMNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$1.05
-0.04-3.21%
At Close: -
$1.12
0.076.16%
After Hours: Sep 20, 6:00 PM EDT
15 minutes delayed
Iterum Therapeutics (ITRM) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Iterum Therapeutics (NASDAQ:ITRM) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Iterum Therapeutics (ITRM)?

A

There have been no specific sales or earnings guidance reported for Iterum Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch